LLSCX
Price
$29.36
Change
-$0.15 (-0.51%)
Updated
Nov 12 closing price
Net Assets
740.06M
NAESX
Price
$122.63
Change
+$0.18 (+0.15%)
Updated
Nov 12 closing price
Net Assets
161.58B
Interact to see
Advertisement

LLSCX vs NAESX

Header iconLLSCX vs NAESX Comparison
Open Charts LLSCX vs NAESXBanner chart's image
Longleaf Partners Small-Cap
Price$29.36
Change-$0.15 (-0.51%)
VolumeN/A
Net Assets740.06M
Vanguard Small Cap Index I
Price$122.63
Change+$0.18 (+0.15%)
VolumeN/A
Net Assets161.58B
LLSCX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
LLSCX vs. NAESX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLSCX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 162B vs. LLSCX (740M). NAESX pays higher dividends than LLSCX: NAESX (1.22) vs LLSCX (0.11). LLSCX was incepted earlier than NAESX: LLSCX (37 years) vs NAESX (65 years). LLSCX (1.04) is less costly to investors than NAESX (0.17). LLSCX is a more actively managed with annual turnover of: 27.00 vs. NAESX (13.00). NAESX has a lower initial minimum investment than LLSCX: NAESX (3000) vs LLSCX (10000). LLSCX annual gain was more profitable for investors over the last year : 3.93 vs. NAESX (1.42). NAESX return over 5 years is better than : 48.22 vs. LLSCX (33.85).
LLSCXNAESXLLSCX / NAESX
Total Expense Ratio0.950.17559%
Annual Report Gross Expense Ratio1.040.17612%
Fund Existence37 years65 years-
Gain YTD7.3106.726109%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets740M162B0%
Annual Yield % from dividends0.111.229%
Returns for 1 year3.931.42276%
Returns for 3 years37.3633.14113%
Returns for 5 years33.8548.2270%
Returns for 10 years25.57137.5819%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI44.540.56
+1.27%
Acadian Asset Management Inc
TAVIU10.44N/A
N/A
Tavia Acquisition Corp
SCM12.07-0.01
-0.08%
STELLUS CAPITAL INVESTMENT Corp
CYTK65.94-0.56
-0.84%
Cytokinetics
CUE0.67-0.02
-2.25%
Cue Biopharma